| Financial Year |
March 31 2022 |
| Monetary Funds |
289,022,859.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
152,212,195.77 |
| Advances to Suppliers |
24,511,203.13 |
| Other Receivables |
211,303,492.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
813,522.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
136,111,435.65 |
| Total Current Assets |
813,974,708.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
46,800,165.56 |
| Investment Properties |
-- |
| Fixed Assetes |
250,835,328.09 |
| Under-construction Projects |
2,817,103,097.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
4,783,377,505.04 |
| Intangible Assets |
278,747,301.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,269,984.20 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
201,349,775.92 |
| Sub-Total of Non-Current Assets |
8,578,459,749.08 |
| Total Assets |
9,392,434,457.63 |
| Short-Term Loans |
2,812,279,086.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
392,060,656.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,697,575.35 |
| Taxes Payable |
43,785,604.91 |
| Interest Payable |
601,593,806.70 |
| Dividend Payable |
-- |
| Other payables |
2,435,453,349.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
357,293,294.12 |
| Other Current Liabilities |
262,035.98 |
| Sub-Total of Current Liabilities |
6,051,039,935.88 |
| Long-term Loans |
1,945,890,549.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,291,664,066.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,805,762,403.94 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,043,317,020.04 |
| Total Liabilities |
17,094,356,955.92 |
| Paid-In Capital(Or Share Stock) |
587,674,264.00 |
| Capital Surplus |
2,808,011,922.29 |
| Surplus Reserve |
47,934,026.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-10,617,334,752.46 |
| Minority Stockholder's Interest |
-319,379,317.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-7,382,543,180.76 |
| Owner's Equity（Stockholder's Equity） |
-7,701,922,498.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,392,434,457.63 |
